Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Illumina    ILMN

ILLUMINA (ILMN)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets
The feature you requested does not exist. However, we suggest the following feature:

Illumina : to Webcast Upcoming Investor Conference Presentation

share with twitter share with LinkedIn share with facebook
share via e-mail
0
11/22/2017 | 03:01pm CET

Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conference, and invites investors to participate via webcast.

Citi Global Healthcare Conference, New York, NY on December 7, 2017 at 11:45 am Eastern Time.

The webcast can be accessed in the Investor Relations section of Illumina's web site under the "company" tab at www.illumina.com.

About Illumina

Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. To learn more, visit www.illumina.com and follow @illumina.


© Business Wire 2017
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ILLUMINA
11/22 ILLUMINA : to Webcast Upcoming Investor Conference Presentation
11/22 Illumina Wins UK Patent Suit Against Premaitha Health, Ariosa Diagnostics
11/21 ILLUMINA : Wins Infringement Suit Against Premaitha Health plc and Ariosa Diagno..
11/21 ILLUMINA : Grows Clinical IVD Portfolio with Introduction of NextSeq™ 550D..
11/21 ILLUMINA : Patent Issued for Confocal Imaging Methods and Apparatus (USPTO 98169..
11/21 ILLUMINA : Patent Issued for Methods for Sequencing Polynucleotides (USPTO 98161..
11/16 ILLUMINA INC : Change in Directors or Principal Officers (form 8-K)
11/15 ILLUMINA : Grows Clinical IVD Portfolio with Introduction of NextSeq™ 550D..
11/09 ILLUMINA, INC. (NASDAQ : ILMN) Files An 8-K Departure of Directors or Certain Of..
11/08 ILLUMINA INC : Change in Directors or Principal Officers (form 8-K)
More news
News from SeekingAlpha
11/20 Illumina, Inc. 2017 Q3 - Results - Earnings Call Slides
11/17 YOUR DAILY PHARMA SCOOP : Gilead CAR-T Potential, Egalet Surges, Aerie Launches ..
11/16 YOUR DAILY PHARMA SCOOP : A Look At Sanofi, Ultragenyx Gets FDA Nod, Capricor Tu..
11/15 Illumina launches new automated NGS system NextSeq 550Dx
11/09 YOUR DAILY PHARMA SCOOP : Portola Upside, Novartis Reports Positive Cosentyx Dat..
Financials ($)
Sales 2017 2 709 M
EBIT 2017 652 M
Net income 2017 812 M
Finance 2017 805 M
Yield 2017 -
P/E ratio 2017 38,40
P/E ratio 2018 51,06
EV / Sales 2017 11,1x
EV / Sales 2018 9,71x
Capitalization 30 959 M
Chart ILLUMINA
Duration : Period :
Illumina Technical Analysis Chart | ILMN | US4523271090 | 4-Traders
Technical analysis trends ILLUMINA
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 18
Average target price 220 $
Spread / Average Target 3,9%
EPS Revisions
Managers
NameTitle
Francis A. deSouza President, Chief Executive Officer & Director
Jay T. Flatley Executive Chairman
Ostadan Omead Executive VP-Operations, Products & Strategy
Sam A. Samad Chief Financial Officer & Senior Vice President
Mostafa Ronaghi Chief Technology Officer & Senior Vice President
Sector and Competitors
1st jan.Capitalization (M$)
ILLUMINA63.25%30 959
THERMO FISHER SCIENTIFIC INC.34.78%76 958
DANAHER19.86%65 512
INTUITIVE SURGICAL85.67%44 650
BOSTON SCIENTIFIC CORPORATION30.65%39 548
ROYAL PHILIPS14.34%36 776